Skip to main content
SpringerLink
Log in

Die anovulatorische Patientin in der Reproduktionsmedizin

  • Chapter
Das Deutsche IVF-Register 1996–2006

  • 451 Accesses

Auszug

Die Anovulation als monokausaler Befund in der Sterilitätsbehandlung hat nicht nur viele differenzialdiagnostisch zu erwägende Ursachen, sondern ist meist sehr suffizient auch ohne den Einsatz assistierter Reproduktionstechniken zu behandeln. Ziel ist dabei das Erreichen einer Ovulation, sei es durch direkte Stimulation oder durch Restaurierung eines eigenen spontanen ovulatorischen Zyklus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Azziz R, Black VY, Knochenhauer ES et al. (1999) Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab 84, 946

    Article  PubMed  CAS  Google Scholar 

  2. Brettenthaler N, De Geyter C, Huber PR, Keller U (2004) Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3835–3840.

    Article  PubMed  CAS  Google Scholar 

  3. Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM (2006) Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 21:109–20.

    Article  PubMed  CAS  Google Scholar 

  4. Cochrane Data base (2003) Insulin sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for PCOS. Cochrane Database Syst Rev (2003) 3, CD003053

    Google Scholar 

  5. Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003 79:1–13.

    Article  PubMed  Google Scholar 

  6. Coulam CB, Adamson SC, Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604–606

    PubMed  CAS  Google Scholar 

  7. Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774–800

    Article  PubMed  CAS  Google Scholar 

  8. Eisenhardt S, Schwarzmann N, Henschel V, Germeyer A, von Wolff M, Hamann A, Strowitzki T. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2006 9:946–52.

    Google Scholar 

  9. Farquhar C, Vandekerckhove P, Lilford R (2003) Laparoscopic »drilling« by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review). In: The Cochrane Library, Issue 1, Oxford: Update Software

    Google Scholar 

  10. Filicori M, Flamigni C, Dellai P et al. (1994) Treatment of anovulation with pulsatile gonadotropin releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215

    Article  PubMed  CAS  Google Scholar 

  11. Garcia J, Seegar Jones GS, Wentz AC (1977) The use of clomiphene citrate. Fertil Steril 28, 707

    PubMed  CAS  Google Scholar 

  12. Homburg R, Levy T, Ben-Rafael Z (1995) A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 63: 729–33.

    PubMed  CAS  Google Scholar 

  13. Klinefelter JF jr, Albright F, Griswold G (1943) Experience with a quantitative test for normal or decreased amounts of follicle stimulating hormone in the urine in endocrinological diagnosis. J Clin Endocrinol Metab 3:529–536.

    Article  CAS  Google Scholar 

  14. Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 2694–2698

    Article  PubMed  CAS  Google Scholar 

  15. Leyendecker G, Wildt L, Plotz EJ (1981) Die hypothalamische Ovarialinsuffizienz. Gynäkologe 14:84–103.

    PubMed  CAS  Google Scholar 

  16. Liguori G, Tolino A, Moccia G, Scognamiglio G, Nappi C (1996) Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome. Gynecol Endocrinol 10, 257–264

    PubMed  CAS  Google Scholar 

  17. Nugent D, Vandekerckhove P, Hughes e et al. (2000) Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane review)

    Google Scholar 

  18. Rebar RW (1982) Hypergonadotropic amenorrhea and premature ovarian failure: a review. J Reprod Med 27:179–186

    PubMed  CAS  Google Scholar 

  19. Rossing MA, Daling JR, Weiss NS et al. (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331, 771

    Article  PubMed  CAS  Google Scholar 

  20. Rotterdam ESHRE/ ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 19–25

    Google Scholar 

  21. Schneider HPG, Hanker JP, Frantzen C (1988) Behandlung der funktionellen und organischen Unfruchtbarkeit — Sterilität/Infertilität. In: Schneider HPG, Lauritzen C, Nieschlag E (Hrsg) Grundlagen und Klinik der menschlichen Fortpflanzung. De Gruyter, Berlin, S 619–746

    Google Scholar 

  22. Strowitzki T, Vogt PH (2003) Genetik des POF-Syndroms. Gynäkologische Endokrinologie 1 128–134

    Article  Google Scholar 

  23. Strowitzki T (2005) Praktisches Vorgehen bei gestörter Ovarfunktion und mit ihr assoziierter Phänomene. In: Leidenberger F, Strowitzki T, Ortmann O (Hrsg) Klinische Endokrinologie für Frauenärzte. Springer Verlag, p 561ff

    Google Scholar 

  24. Weise W, Honza A, Prügel P (1982) Behandlungsergebnisse bei funktioneller weiblicher Sterilität. Zentralbl Gynäkol 104, 9

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. für Gynäkologische Endokrinologie und Fertilitätsstörung, Universitätsklinikum, Voßstraße 9, 69115, Heidelberg

    T. Strowitzki (Prof. Dr. med.)

  2. Universitätsklinik für Frauenheilkunde, Anichstraße 35, 6020, Innsbruck, Österreich

    L. Wildt (Prof. Dr. med.)

Authors
  1. T. Strowitzki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Wildt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Strowitzki, T., Wildt, L. (2007). Die anovulatorische Patientin in der Reproduktionsmedizin. In: Das Deutsche IVF-Register 1996–2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49928-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-49928-2_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-37324-7

  • Online ISBN: 978-3-540-49928-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation